Pathophysiology of LPS-induced gastrointestinal injury in the rat: Role of secretory phospholipase A2

Shock

Volumn 30, Issue 2, 2008, Pages 206-211

  Zayat, Mayssa ^a   Lichtenberger, Lenard M ^b   Dial, Elizabeth J ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Ileum; Lyso phosphatidylcholine; Permeability; Phosphatidylcholine; Stomach

Indexed keywords

5 [4 BENZYLOXYPHENYL] [7 PHENYLHEPTANOYLAMINO]PENTANOIC ACID; DEXTRAN 40; ENDOTOXIN; ENZYME INHIBITOR; ISOTHIOCYANIC ACID; LIPOPOLYSACCHARIDE; PHOSPHOLIPID; SECRETORY PHOSPHOLIPASE A2; UNCLASSIFIED DRUG; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; ENDOTOXEMIA; ENZYME ACTIVITY; ILEUM; IN VIVO STUDY; INTESTINE MUCOSA PERMEABILITY; LIPID MEMBRANE; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT; SEPSIS; STOMACH; STOMACH CONTENT; THIN LAYER CHROMATOGRAPHY; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; ENZYME SPECIFICITY; ENZYMOLOGY; GASTROINTESTINAL MOTILITY; HUMAN; INTESTINE MUCOSA; METABOLISM; PERMEABILITY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STOMACH MUCOSA;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; GASTRIC MUCOSA; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MALE; PERMEABILITY; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASES A2, SECRETORY; RATS; RATS, SPRAGUE-DAWLEY; SUBSTRATE SPECIFICITY;

EID: 52149122500     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318160f47f     Document Type: Article

References (29)

1. Wirthlin DJ, Cullen JJ, Spates ST, Conklin JL, Murray J, Caropreso DK, Ephgrave KS: Gastrointestinal transit during endotoxemia: the role of nitric oxide. J Surg Res 60:307-311, 1996.
2. Deitch EA, Berg R, Specian R: Endotoxin promotes the translocation of bacteria from the gut. Arch Surg 122:186-190, 1987.
3. Sappington PL, Han X, Yang R, Delude RL, Fink MP: Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated caco-2 enterocytic monolayers. J Pharmacol Exp Ther 304:464-476, 2003.
4. Fink M: Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr Opin Crit Care 9:143-151, 2003.
5. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC: Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 34(4):385-396, 2002.
6. Touqui L, Alaoui-El-Azher M: Mammalian secreted phospholipase A2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med 1:739-754, 2001.
7. Lilja I, Dimberg J, Sjodahl R, Tagesson C, Gustafson- Svard C: Effects of endotoxin and dexamethasone on group I and II phospholipase A2 in rat ileum and stomach. Gut 35:40-45, 1994.
8. Nevalainen TJ, Haapamaki MM, Gronroos JM: Roles of secretory phospholipase A2 in inflammatory diseases and trauma. Biochim Biophys Acta 1488:83-90, 2000.
9. Sawai T, Lampman R, Hua Y, Segura B, Drongowski RA, Coran AG, Harmon CM: Lysophosphatidylcholine alters enterocyte monolayer permeability via a protein kinase C/Ca2+ mechanism. Pediatr Surg Int 18(7):591-594, 2002.
10. Tagesson C, Sjodahl R, Thoren B: Passage of molecules through the wall of the gastrointestinal tract. Scand J Gastroenterol 13:519-524, 1987.
11. Yan S, Chai H, Wang H, Yang H, Nan B, Yao Q, Chen C: Effects of lysophospatidylcholine on monolayer cell permeability of human coronary artery endothelial cells. Surgery 138(3):464-473, 2005.
12. Hills BA, Buttler BD, Lichtenberger LM: Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach. Am J Physiol 244:G561-G568, 1983.
13. Ya-Chu JK, Lichtenberger LM: Localization of phospholipid-rich zones in rat gastric mucosa: possible origin of a protective hydrophobic luminal lining. J Histochem Cytochem 35(11):1285-1298, 1987.
14. Dial EJ, Romero JJ, Villa X, Mercer D, Lichtenberger LM: Lipopolysaccharide-induced gastrointestinal injury in rats: role of surface hydrophobicity and bile salts. Shock 17(1):77-80, 2002.
15. Harris MS, Kennedy JG, Siegesmund KA, Yorde DE: Relationship between distention and absorption in rat intestine. Gastroenterology 94:1164-1171, 1988.
16. Sandberg JW, Lau C, Jacomino M, Finegold M, Henning SJ: Improving access to intestinal stem cells as a step toward intestinal gene transfer. Hum Gene Ther 5:323-329, 1994.
17. Ottlecz A, Romero JJ, Hazell SL, Graham DY, Lichtenberger LM: Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and Biophysical Studies. Dig Dis Sci 38(11):2071-2080, 1993.
18. Folch J, lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226(1):497-509, 1957.
19. Rouser G, Fleischer S, Yamamoto A: Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5(5):494-496, 1970.
20. Nevalainen TJ, Gronroos JM, Kallajoki M: Expression of group II phospholipase A2 in the human gastrointestinal tract. Lab Invest 72:201-208, 1995.
21. Huhtinen HT, Gronroos JM, Haapamki MM, Nevalainen TJ: Source of group II phospholipase A2 in gastric juice. Scand J Clin Lab Invest 62(2):123-128, 2002.
22. Sonnino RE, Burchett S, Sharma A, Harris LK, Franson RC: Secretory phospholipase A2 levels in rat small bowel. J Invest Surg 9(4):313-319, 1996.
23. Chaminade B, Le Balle F, Fourcade O, Nauze M, Delagebeaudeuf C, Gassama-Diagne A, Simon M-F, Fauvel J, Chap H: New developments in phospholipase A2. Lipids 34(Suppl 1):49-55, 1999.
24. Tomita Y, Jyoyama H, Kobayashi M, Kuwabara K, Furue S, Uneo M, Yamada K, Ono T, Teshirogi I, Nomura K, et al.: Role of group IIA phospholipase A2 in rat colitis induced by dextran sulfate sodium. Eur J Pharmacol 472(1-2):147-158, 2003.
25. Sturm A, Dignass AU: Modulation of gastrointestinal wound repair and inflammation by phospholipids. Biochim Biophys Acta 1582(1-3):282-288, 2002.
26. Chang J, Gilman SC, Lewis AJ: Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: a possible signal for IL-1 action. J Immunol 136(4):1283-1287, 1986.
27. Nakano T, Arita H: Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid. FEBS Lett 273(1-2):23Y26, 1990.
28. Hansford KA, Reid RC, Clark CI, Tyndall JDA, Whitehouse MW, Guthrie T, McGeary RP, Schafer K, Martin JL, Fairlie DP: D-tyrosine as a chiral precursor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with anti-inflammatory activity. Chem Biochem 4(2-3):181-185, 2003.
29. Arumugam TV, Arnold N, Proctor L, Newman M, Reid RC, Hansford KA, Fairlie DP, Shiels IA, Taylor SM: Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA2, COX-1, COX-2 selective inhibitors and LTC4 receptor antagonist. Br J Pharmacol 140(1):71-80, 2003.